- Economy
- Education And Career
- Companies & Markets
- Gadgets & Technology
- After Hours
- Healthcare
- Banking & Finance
- Entrepreneurship
- Energy & Infra
- Case Study
- Video
- More
- Sustainability
- Web Exclusive
- Opinion
- Luxury
- Legal
- Property Review
- Cloud
- Blockchain
- Workplace
- Collaboration
- Developer
- Digital India
- Infrastructure
- Work Life Balance
- Test category by sumit
- Sports
- National
- World
- Entertainment
- Lifestyle
- Science
- Health
- Tech
Latest Articles in drugs
Two Indian Generics Makers End Battle To Copy Drugs Amid Patent Debate
Two Indian drugmakers said they had given up a battle to copy drugs developed by Bristol Myers Squibb and AstraZeneca , blaming a lack of government support for cheap generics and pressure from Big Pharma
Read More
Pfizer, Allergan Scrap $160 Billion Deal After US Tax Rule Change
US drugmaker Pfizer Inc and Ireland-based Allergan Plc walked away from their $160 billion merger on Wednesday, a major win for President Barack Obama, who has been pushing to curb deals in which companies move overseas to save on taxes
Read More
Lupin Says It Sees No Supply Disruption At Plant Despite FDA Observations
The company said it did not expect any disruption to supply from its main manufacturing plant despite what it called minor observations made by the US Food and Drug Administration after an audit
Read More
Cadila's Shares Fall After WHO Faults Vaccines Plant Standards
Cadila Healthcare's shares fell on Wednesday after the World Health Organization cited violations of manufacturing and clinical standards at one of the drugmaker's vaccines factory in Gujarat
Read More
Delhi High Court Extends Relief To Pharma Firms In Drug Ban Case
The Delhi High Court restrained the government from enforcing a ban on hundreds of drugs for another week on Monday until it has heard petitions from drugmakers challenging the order
Read More
Drugs Ban | Partial Relief From High Court For Wockhardt, Glaxo And Griffon
The drugs which were subject matter of today's plea are Aceproxyvon, Viscodyne and Viscodyne-D of Wockhardt, Crocin Cold and Flu Max of Glaxo and Grilinctus syrup of Griffon.
Read More
Emcure Pharma Gets US FDA Warning Letter; Indian Drug Industry Vows For Quality Excellence
The US Food and Drug Administration has warned Indian generic drugmaker Emcure Pharmaceuticals, saying it repeatedly fudged test records at its plant at Pune
Read More
US Industry Body Says India Agreed To Not Issue 'Compulsory' Drug Licences
India has given private assurances that it will not grant licences allowing local firms to override patents and make cheap copies of drugs by big Western drugmakers, a US business advocacy group said
Read More
US, EU Regulators Urge Indian Drug Companies To Step Up Standards
India supplies about 33 per cent of the medicines sold in the United States, and nearly a quarter sold in the UK
Read More
Cipla Completes $550 Million Acquisition Of Two US Firms
With this acquisition, pharmaceutical firm Cipla will have more relevance to wholesale and retail customers
Read More
Sun Pharma Q3 Profit Beats Street, To Wind Down JV With Merck
The company posts net earnings for the quarter ended December 31 of Rs 1,417 crore, compared with Rs 1,425 crore a year earlier
Read More
Cipla's Q3 Profit Hurt By One-off Charge
The company posted a net profit of Rs 343 crore for the quarter ended December 31, slightly above the Rs 328 crore reported a year earlier
Read More
2015 Marks Mixed Trend For Pharma Sector
The Rs 1,50,000 crore worth drugs pharmaceuticals industry is currently one of the most robust sectors in India
Read More
USFDA Gives Dr Reddy’s Extra Time To Respond To Warning Letter
Dr Reddy’s Laboratories Ltd on Thursday said the USFDA has extended the time-frame for replying to the warning letter issued to the company by about two weeks to December 7
Read More